The accumulation of 131-iodine is known to occur in the extrathyroidal tissues, such as the salivary glands and the gastrointestinal tract during radioactive iodine therapy. It is considered to be due to the expression of sodium iodide symporter. A 36-year-old lactating female was treated for remnant ablation for papillary thyroid carcinoma (pT1bN1bM0 pStage I) on the condition that she refrained from breastfeeding and was separated from her child and was milked to promote the excretion of 131-iodine until the accumulation disappeared on scintigram imaging. Scintigram showed the decrease and disappearance of the 131-iodine accumulation and the external dose rate was measured and confirmed to have decreased on the day 7 and 14 after the treatment. In conclusion, remnant ablation may be available by milking and separation from the child for 7 to 14 days.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429622PMC
http://dx.doi.org/10.1016/j.radcr.2021.08.035DOI Listing

Publication Analysis

Top Keywords

remnant ablation
12
accumulation 131-iodine
8
ablation papillary
8
papillary thyroid
8
thyroid carcinoma
8
131-iodine accumulation
8
case accumulation
4
131-iodine
4
131-iodine mammary
4
mammary gland
4

Similar Publications

Attempted ablation of an orbital cyst in a dog with 1% polidocanol using fluoroscopy and contrast cystography.

Vet Ophthalmol

January 2025

Cardiology & Cardiac Surgery, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.

A 4-year-old female spayed mixed-breed dog received enucleation surgery of the right eye in 2018 following the diagnosis of glaucoma. The patient was presented in 2021 for recurrent swelling of the right orbit. Ultrasound confirmed the presence of a cystic structure, and chemical ablation with 1% polidocanol (compounded, Stokes Pharmacy, Mt.

View Article and Find Full Text PDF

Introduction: Differentiated thyroid cancer (DTC) is the most common type of endocrine malignancy, with rising incidence over recent decades. Despite a favorable prognosis, DTC management remains complex, often involving thyroidectomy followed by radioactive iodine (RAI) therapy. While RAI is crucial for patient outcomes, its efficacy varies, necessitating the identification of predictors for treatment response.

View Article and Find Full Text PDF
Article Synopsis
  • Uterine arteriovenous malformations (UAVMs) are a rare cause of heavy bleeding after childbirth, often linked to placenta accreta spectrum (PAS).
  • A case study highlighted a woman with PAS who experienced significant bleeding post-delivery and required several treatments, including uterine artery embolization, which proved effective.
  • The study suggests that UAVMs may arise from residual PAS tissue and emphasizes the importance of preserving fertility while managing severe bleeding, avoiding more drastic measures like hysterectomy.
View Article and Find Full Text PDF

One step closer to the end of postoperative radioactive iodine thyroid remnant ablation.

Lancet Diabetes Endocrinol

January 2025

Department of Nuclear Medicine and Radiology, UMC Utrecht, Utrecht, Netherlands.

View Article and Find Full Text PDF
Article Synopsis
  • Dyslipidemia significantly increases the risk of developing cardiovascular diseases (CVD), highlighting the need for better predictive models tailored for those with high lipid levels.
  • Researchers conducted a study using data from over 23,000 hyperlipidemic patients to test machine-learning algorithms against traditional risk assessment tools for predicting CVD onset.
  • The LightGBM algorithm performed best with an AUROC of 0.883, surpassing the logistic regression model (0.725) and traditional risk scores, while findings suggested that blood lipid levels and remnant cholesterol are key indicators of CVD risk.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!